Literature DB >> 22011203

Overexpression of Bcl-2-associated death inhibits A549 cell growth in vitro and in vivo.

Na Huang1, Jing Zhu, Dan Liu, Ya-Lun Li, Bo-Jiang Chen, Yan-Qi He, Kun Liu, Xian-Ming Mo, Wei-Min Li.   

Abstract

The importance of apoptosis during the process of inhibiting tumorigenesis has been recognized. The role of BH3-only proapoptotic protein Bcl-2-associated death (BAD) in tumor growth remains controversial. The aim of this study was to explore the role of BAD in lung cancer cells. Our study showed that expression of BAD was upregulated in A549 cells by a recombinant lentivirus overexpressing BAD. In vitro, BAD overexpression significantly inhibited A549 cell proliferation and induced apoptosis in cell proliferation and apoptosis assays, respectively. The effect of BAD on A549 cells was studied in tumor xenograft of nude mice and the results showed that the tumor volume in the experimental group was smaller than the control groups. Further, immunohistochemical technique was used to determine the cell proliferation and apoptosis status of the lung tumor xenograft cells. This demonstrated that the in vivo and in vitro results were consistent. Taken together, our results indicate that overexpression of BAD inhibits the growth of A549 cells in vitro and in vivo, through inhibiting cell proliferation and inducing apoptosis. Thus, BAD could be a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22011203      PMCID: PMC3304250          DOI: 10.1089/cbr.2011.1018

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  27 in total

1.  Bad-deficient mice develop diffuse large B cell lymphoma.

Authors:  Ann M Ranger; Jiping Zha; Hisashi Harada; Sandeep Robert Datta; Nika N Danial; Andrew P Gilmore; Jeffery L Kutok; Michelle M Le Beau; Michael E Greenberg; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-22       Impact factor: 11.205

2.  Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1.

Authors:  Romaine Fernando; James S Foster; Amber Bible; Anders Ström; Richard G Pestell; Mahadev Rao; Arnold Saxton; Seung Joon Baek; Kiyoshi Yamaguchi; Robert Donnell; Maria Cekanova; Jay Wimalasena
Journal:  J Biol Chem       Date:  2007-08-01       Impact factor: 5.157

Review 3.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

Authors:  Qing-Bai She; David B Solit; Qing Ye; Kathryn E O'Reilly; Jose Lobo; Neal Rosen
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

6.  Cancer trends in China.

Authors:  Ping Zhao; Min Dai; Wanqing Chen; Ni Li
Journal:  Jpn J Clin Oncol       Date:  2010-01-18       Impact factor: 3.019

7.  Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma.

Authors:  Ronell Bologna-Molina; Adalberto Mosqueda-Taylor; Eduardo Lopez-Corella; Oslei Paes de Almeida; Daniel Carrasco-Daza; José E Farfán-Morales; Nelly Molina-Frechero; Pablo Damián-Matsumura
Journal:  Pathol Int       Date:  2009-04       Impact factor: 2.534

8.  Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells.

Authors:  Bo-Hwa Choi; Wanil Kim; Qiuxia Chelsia Wang; Dong-Chan Kim; Swee Ngin Tan; Jean Wan Hong Yong; Kyong-Tai Kim; Ho Sup Yoon
Journal:  Cancer Lett       Date:  2007-12-26       Impact factor: 8.679

9.  Bcl-2 family members as molecular targets in cancer therapy.

Authors:  Isabel Marzo; Javier Naval
Journal:  Biochem Pharmacol       Date:  2008-06-28       Impact factor: 5.858

10.  Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction.

Authors:  Chen-Tzu Kuo; Ming-Jen Hsu; Bing-Chang Chen; Chien-Chih Chen; Che-Ming Teng; Shiow-Lin Pan; Chien-Huang Lin
Journal:  Toxicol Lett       Date:  2007-12-28       Impact factor: 4.372

View more
  5 in total

1.  Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis.

Authors:  Claudia Gherman; Ovidiu Leonard Braicu; Oana Zanoaga; Anca Jurj; Valentina Pileczki; Mahafarin Maralani; Flaviu Drigla; Cornelia Braicu; Liviuta Budisan; Patriciu Achimas-Cadariu; Ioana Berindan-Neagoe
Journal:  Mol Cell Biochem       Date:  2016-02-02       Impact factor: 3.396

2.  Analysis of PI3K pathway components in human cancers.

Authors:  Jamila Daragmeh; Waseim Barriah; Bashar Saad; Hilal Zaid
Journal:  Oncol Lett       Date:  2016-03-08       Impact factor: 2.967

3.  Silencing of CD276 suppresses lung cancer progression by regulating integrin signaling.

Authors:  Fang Li; Hengchi Chen; Dali Wang
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

4.  BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer.

Authors:  Li Jiang; Man Luo; Dan Liu; Bojiang Chen; Wen Zhang; Lin Mai; Jing Zeng; Na Huang; Yi Huang; Xianming Mo; Weimin Li
Journal:  Cancer Cell Int       Date:  2013-06-01       Impact factor: 5.722

5.  Expression and Functional Analysis of the BCL2-Associated Agonist of Cell Death (BAD) Gene in the Sheep Ovary During the Reproductive Cycle.

Authors:  Xiaohan Cao; Xiangyu Wang; Lulu Lu; Xiaoyu Li; Ran Di; Xiaoyun He; Wenping Hu; Xianyin Zeng; Qiuyue Liu; Mingxing Chu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-19       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.